medical weight-loss market alone now exceeds $33.8 billion , more than doubling since 2022 with telehealth platforms capturing a rapidly expanding share
FDA approval means regulatory standards were met, but suitability for individual patients requires medical evaluation
Once blood levels reach steady state through daily dosing, the long half-life of semaglutide (approximately 7 days) means levels do not drop dramatically between doses
Whether this can be sustained with a GLP-1 medication, however, is yet to be confirmed, says Florida-based gastroenterologist Dr
GH Insensitivity Syndrome Collaborative Group (2007) Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity
Many patients avoid GLP-1s mainly because of injections, so an oral option is great news